 | • レポートコード：MRC2303J0225 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、226ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界のセーフティシリンジ市場規模が2021年に6,627.09百万ドル、2022年には7,256.84百万ドルに到達し、今後CAGR 9.67％で成長して2027年までに11,536.68百万ドルまで拡大すると予測しています。当調査資料では、セーフティシリンジの世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、用途別（麻酔、血液検体採取、ドラッグデリバリー、ワクチン）分析、エンドユーザー別（クリニック、糖尿病患者、家庭医療、不妊患者、病院＆HMO）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Axel Bio Corporation、B. Braun Melsungen AG、Baxter Healthcare Corporation、Becton, Dickinson and Company、Boston Scientific Corporation、Cardinal Health, Inc、Covidien、Gerresheimer AG、Hindustan Syringes & Medical Devices Ltdなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のセーフティシリンジ市場規模：用途別 - 麻酔における市場規模 - 血液検体採取における市場規模 - ドラッグデリバリーにおける市場規模 - ワクチンにおける市場規模 ・世界のセーフティシリンジ市場規模：エンドユーザー別 - クリニックにおける市場規模 - 糖尿病患者における市場規模 - 家庭医療における市場規模 - 不妊患者における市場規模 - 病院＆HMOにおける市場規模 ・世界のセーフティシリンジ市場規模：地域別 - 南北アメリカのセーフティシリンジ市場規模 アメリカのセーフティシリンジ市場規模 カナダのセーフティシリンジ市場規模 ブラジルのセーフティシリンジ市場規模 ... - アジア太平洋のセーフティシリンジ市場規模 日本のセーフティシリンジ市場規模 中国のセーフティシリンジ市場規模 インドのセーフティシリンジ市場規模 韓国のセーフティシリンジ市場規模 台湾のセーフティシリンジ市場規模 ... - ヨーロッパ/中東/アフリカのセーフティシリンジ市場規模 イギリスのセーフティシリンジ市場規模 ドイツのセーフティシリンジ市場規模 フランスのセーフティシリンジ市場規模 ロシアのセーフティシリンジ市場規模 ... - その他地域のセーフティシリンジ市場規模 ・競争状況 ・企業情報 |
The Global Safety Syringes Market size was estimated at USD 6,627.09 million in 2021 and expected to reach USD 7,256.84 million in 2022, and is projected to grow at a CAGR 9.67% to reach USD 11,536.68 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Safety Syringes to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Application, the market was studied across Anesthesia, Blood Specimen Collection, Drug Delivery, and Vaccination.
Based on End-User, the market was studied across Clinics, Diabetic Patients, Family Practices, Fertility Patients, Hospitals and HMOs, and Pharmacies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Safety Syringes market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Safety Syringes Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Safety Syringes Market, including Axel Bio Corporation, B. Braun Melsungen AG, Baxter Healthcare Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc, Covidien, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd, JMI Syringes & Medical Devices Limited, Lifelong Meditech Private Limited., Medtronic Plc, Nipro Medical Corporation, Novo Nordisk A/S, Retractable Technologies, Inc., Sartorius AG, Smiths Medical, Smiths Medical, Inc., Sol-Millennium Medical Group, Terumo Medical Corporation, UltiMed, Inc, Unilife, and Valco Instruments Co. Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Safety Syringes Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Safety Syringes Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Safety Syringes Market?
4. What is the competitive strategic window for opportunities in the Global Safety Syringes Market?
5. What are the technology trends and regulatory frameworks in the Global Safety Syringes Market?
6. What is the market share of the leading vendors in the Global Safety Syringes Market?
7. What modes and strategic moves are considered suitable for entering the Global Safety Syringes Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Risk of exposure to blood-borne diseases through needlestick injuries and other sharp object injuries
5.1.1.2. Single-handed application of the safety mechanism to activate in all models of safety syringes, factors like operation time, accuracy, and prompt use
5.1.1.3. Healthcare organizations guideline on the use of safety- syringes for intramuscular, intradermal and subcutaneous injections
5.1.2. Restraints
5.1.2.1. High cost of safety syringes and availability of alternative drug delivery methods
5.1.3. Opportunities
5.1.3.1. Increasing number of patients treating themselves in the home reducing risk of needlestick injuries
5.1.3.2. Advancement in tamper-evident closure combined with anti-counterfeiting features such as RFID
5.1.4. Challenges
5.1.4.1. Lack of awareness regarding healthcare and safety issues in emerging economies
5.2. Cumulative Impact of COVID-19
6. Safety Syringes Market, by Application
6.1. Introduction
6.2. Anesthesia
6.3. Blood Specimen Collection
6.4. Drug Delivery
6.5. Vaccination
7. Safety Syringes Market, by End-User
7.1. Introduction
7.2. Clinics
7.3. Diabetic Patients
7.4. Family Practices
7.5. Fertility Patients
7.6. Hospitals and HMOs
7.7. Pharmacies
8. Americas Safety Syringes Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Safety Syringes Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Safety Syringes Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Axel Bio Corporation
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. B. Braun Melsungen AG
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Baxter Healthcare Corporation
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Becton, Dickinson and Company
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Boston Scientific Corporation
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Cardinal Health, Inc
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Covidien
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Gerresheimer AG
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Hindustan Syringes & Medical Devices Ltd
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. JMI Syringes & Medical Devices Limited
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Lifelong Meditech Private Limited.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Medtronic Plc
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Nipro Medical Corporation
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Novo Nordisk A/S
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Retractable Technologies, Inc.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Sartorius AG
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Smiths Medical
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Smiths Medical, Inc.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Sol-Millennium Medical Group
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Terumo Medical Corporation
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. UltiMed, Inc
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Unilife
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Valco Instruments Co. Inc.
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing